Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy
- PMID: 38820162
- PMCID: PMC11141634
- DOI: 10.1126/sciadv.adn6615
Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy
Abstract
Visceral myopathy is a life-threatening disease characterized by muscle weakness in the bowel, bladder, and uterus. Mutations in smooth muscle γ-actin (ACTG2) are the most common cause of the disease, but the mechanisms by which the mutations alter muscle function are unknown. Here, we examined four prevalent ACTG2 mutations (R40C, R148C, R178C, and R257C) that cause different disease severity and are spread throughout the actin fold. R178C displayed premature degradation, R148C disrupted interactions with actin-binding proteins, R40C inhibited polymerization, and R257C destabilized filaments. Because these mutations are heterozygous, we also analyzed 50/50 mixtures with wild-type (WT) ACTG2. The WT/R40C mixture impaired filament nucleation by leiomodin 1, and WT/R257C produced filaments that were easily fragmented by smooth muscle myosin. Smooth muscle tropomyosin isoform Tpm1.4 partially rescued the defects of R40C and R257C. Cryo-electron microscopy structures of filaments formed by R40C and R257C revealed disrupted intersubunit contacts. The biochemical and structural properties of the mutants correlate with their genotype-specific disease severity.
Figures
References
-
- Soh H., Fukuzawa M., Kubota A., Kawahara H., Ueno T., Taguchi T., Megacystis microcolon intestinal hypoperistalsis syndrome: A report of a nationwide survey in Japan. J. Pediatr. Surg. 50, 2048–2050 (2015). - PubMed
-
- Tang P., Lu L., Yan W., Tao Y., Feng H., Cai W., Wang Y., Long-term follow-up for pediatric intestinal pseudo-obstruction patients in China. Nutr. Clin. Pract. 38, 648–656 (2023). - PubMed
-
- Batzir N. A., Bhagwat P. K., Larson A., Akdemir Z. C., Baglaj M., Bofferding L., Bosanko K. B., Bouassida S., Callewaert B., Cannon A., Colon Y. E., Garnica A. D., Harr M. H., Heck S., Hurst A. C. E., Jhangiani S. N., Isidor B., Littlejohn R. O., Liu P., Magoulas P., Fan H. M., Marom R., McLean S., Nezarati M. M., Nugent K. M., Petersen M. B., Rocha M. L., Roeder E., Smigiel R., Tully I., Weisfeld-Adams J., Wells K. O.; Baylor-Hopkins Center for Mendelian Genomics, Posey J. E., Lupski J. R., Beaudet A. L., Wangler M. F., Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy. Hum. Mutat. 41, 641–654 (2020). - PMC - PubMed
-
- Geraghty R. M., Orr S., Olinger E., Neatu R., Barroso-Gil M., Mabillard H.; Genomics England Research Consortium, Wilson I., Sayer J. A., Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome. J. Rare Dis. (Berlin) 2, 9 (2023). - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
